cbdMD (YCBD) Current Assets (2016 - 2026)
cbdMD (YCBD) posted Current Assets of $8.2 million for Q4 2025, up 24.64% sequentially from $6.6 million in Q3 2025, and up 28.37% YoY from $6.4 million in Q4 2024.
cbdMD (YCBD) Current Assets (2016 - 2026) Analysis & Trends
cbdMD has reported Current Assets for 10 years, with the latest figure at $8.2 million in Q4 2025.
- Quarterly Current Assets rose 28.37% year-over-year to $8.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.2 million (up 28.37% YoY) and the FY2025 annual result came in at $6.6 million, up 2.54% from the prior year.
- Current Assets climbed to $8.2 million in Q4 2025 per YCBD's latest filing, from $6.6 million in the prior quarter.
- Over five years, Current Assets peaked at $36.5 million in Q3 2021 and troughed at $5.6 million in Q2 2025.
- A 5-year average of $14.6 million and a median of $9.1 million in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2021 and 2022: Current Assets soared 53.94% in 2021, then sank 61.15% in 2022.
- Over 5 years, Current Assets stood at $29.7 million in 2021, then tumbled by 61.15% to $11.5 million in 2022, then slumped by 36.11% to $7.4 million in 2023, then retreated by 13.65% to $6.4 million in 2024, then increased by 28.37% to $8.2 million in 2025.
- According to Business Quant data, Current Assets over the past three periods registered $8.2 million, $6.6 million, and $5.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.22 Bn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 7.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.70 Mn |
| Dec 31, 2025 | 8.17 Mn |
| Sep 30, 2025 | 6.55 Mn |
| Jun 30, 2025 | 5.60 Mn |
| Mar 31, 2025 | 6.19 Mn |
| Dec 31, 2024 | 6.36 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | 7.29 Mn |
| Mar 31, 2024 | 7.41 Mn |
| Dec 31, 2023 | 7.37 Mn |
| Sep 30, 2023 | 8.07 Mn |
| Jun 30, 2023 | 10.09 Mn |
| Mar 31, 2023 | 10.15 Mn |
| Dec 31, 2022 | 11.53 Mn |
| Sep 30, 2022 | 16.01 Mn |
| Jun 30, 2022 | 19.86 Mn |
| Mar 31, 2022 | 24.33 Mn |
| Dec 31, 2021 | 29.68 Mn |
| Sep 30, 2021 | 36.50 Mn |
| Jun 30, 2021 | 29.98 Mn |